CRDL · Cardiol Therapeutics Inc.
Market Cap
$226.64M
Shares
116.82M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-12 | 2026-06-30 | |
| Investor Event Transcript | 2026-08-11 | 2026-09-30 | |
| 6-K | 2026-08-05 | — | |
| 6-K | 2026-07-14 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-06-25 | — | |
| 6-K | 2026-06-23 | — | |
| 6-K | 2026-05-26 | 2026-05-25 | |
| Investor Event Transcript | 2026-05-19 | 2026-06-30 | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-11 | 2026-03-31 | |
| 6-K | 2026-05-07 | — | |
| 6-K | 2026-04-28 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-10 | — | |
| 6-K | 2026-04-01 | — | |
| 40-F | 2026-03-31 | 2025-12-31 | |
| 6-K | 2026-02-25 | — | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-02-02 | 2026-01-23 | |
| 6-K | 2026-01-26 | — | |
| 6-K | 2026-01-23 | — | |
| 6-K | 2026-01-16 | — | |
| 6-K | 2026-01-13 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-13 | 2025-09-30 | |
| 6-K | 2025-11-13 | — | |
| 6-K | 2025-11-05 | — | |
| 6-K | 2025-10-28 | 2025-10-27 | |
| 6-K | 2025-10-27 | — | |
| 6-K | 2025-10-21 | — | |
| 6-K | 2025-10-17 | — | |
| 6-K | 2025-08-14 | 2025-06-30 | |
| 6-K | 2025-08-11 | — | |
| 6-K | 2025-08-06 | — | |
| 6-K | 2025-07-22 | — | |
| 6-K | 2025-05-29 | — | |
| 6-K | 2025-05-27 | — | |
| 6-K | 2025-05-14 | 2025-03-31 | |
| 6-K | 2025-04-29 | — | |
| 6-K | 2025-04-28 | 2024-12-31 | |
| 6-K | 2025-04-16 | — | |
| 6-K | 2025-04-01 | — | |
| 40-F | 2025-03-31 | 2024-12-31 | |
| 6-K | 2025-03-14 | — | |
| 6-K | 2025-03-03 | — | |
| 6-K | 2025-02-20 | — | |
| 6-K | 2025-02-04 | — | |
| 6-K | 2024-11-18 | — | |
| 6-K | 2024-11-14 | 2024-09-30 |
Showing 1–50 of 133 filings
Key facts
CIK
1702123
CUSIP
14161Y200
13F (30d)
40 filings
39 filers
Visit website
Investor relations